---
figid: PMC9576517__ijbsv18p5681g002
figtitle: 'Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms
  and pharmacotherapies'
organisms:
- Olea europaea
- Salvia rosmarinus
- Capsella bursa-pastoris
- Erica multiflora
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- gut metagenome
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9576517
filename: ijbsv18p5681g002.jpg
figlink: /pmc/articles/PMC9576517/figure/F2/
number: F2
caption: 'The pathogenesis and therapeutic targets of NAFLD/NASH. A: In hepatocytes,
  lipid synthesis, mitochondrial energy homeostasis, endoplasmic reticulum stress,
  novel mechanisms of peroxisomal involvement in the pathogenesis of NAFLD. The lipotoxicity
  arising from free fatty acid produced in hepatocytes elevates the secretion of cytokines
  and chemokines that affect other non-parenchymal cells, including kupffer cells,
  HSC, LESC. B-C: AcAc secreted by hepatocyte mitochondria can enter macrophages across
  cells, and metabolites of ECM can inhibit HSC activation when catalyzed by SCOT.
  Some pathways such as the MerTK-ERK1/2 pathway, produce TGF-β, which stimulates
  the activation of HSC. Anx A5 is a protein that influences the phenotypic switch
  from M1 to M2 in hepatic macrophages, which secrete cytokines with pro-inflammatory
  effects. D: HSC is stimulated by secreted proteins from other cell types and switches
  from a resting state to an activated state, producing collagen which in turn causes
  fibrosis. E-F: LSEC secretes VCAM-1 in a lipotoxic environment, and monocytes have
  receptors for VCAM-1 on their surface. Adhesion of LSEC to monocytes can contribute
  to the conversion of monocytes to M2 macrophages. G: CD8 T-cell production of auto-aggression
  involves IL-15-driven transcriptional programming. Self-attack by CD8 T cells in
  the liver is involved in liver injury via cell death pathways. Abbreviations: DNL:
  de novo lipogenesis; ECM: extra cellular matrix; IRE1a: nucleus signaling 1; LSEC:
  Liver sinusoids endothelial cell; PGC1a: PPAR-gamma co-activator-1 alpha; PSS1:
  phosphatidylserine synthase1; SCOT: succinyl-CoA:3-ketoacid CoA transferase; TBK1:
  TANK-binding kinase 1; VCAM1: vascular cell adhesion molecule-1.'
papertitle: 'Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms
  and pharmacotherapies.'
reftext: Tingyu Fang, et al. Int J Biol Sci. 2022;18(15):5681-5697.
year: '2022'
doi: 10.7150/ijbs.65044
journal_title: International Journal of Biological Sciences
journal_nlm_ta: Int J Biol Sci
publisher_name: Ivyspring International Publisher
keywords: Drug discovery | mouse model | NAFLD | NASH | pharmacotherapy
automl_pathway: 0.9278293
figid_alias: PMC9576517__F2
figtype: Figure
redirect_from: /figures/PMC9576517__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9576517__ijbsv18p5681g002.html
  '@type': Dataset
  description: 'The pathogenesis and therapeutic targets of NAFLD/NASH. A: In hepatocytes,
    lipid synthesis, mitochondrial energy homeostasis, endoplasmic reticulum stress,
    novel mechanisms of peroxisomal involvement in the pathogenesis of NAFLD. The
    lipotoxicity arising from free fatty acid produced in hepatocytes elevates the
    secretion of cytokines and chemokines that affect other non-parenchymal cells,
    including kupffer cells, HSC, LESC. B-C: AcAc secreted by hepatocyte mitochondria
    can enter macrophages across cells, and metabolites of ECM can inhibit HSC activation
    when catalyzed by SCOT. Some pathways such as the MerTK-ERK1/2 pathway, produce
    TGF-β, which stimulates the activation of HSC. Anx A5 is a protein that influences
    the phenotypic switch from M1 to M2 in hepatic macrophages, which secrete cytokines
    with pro-inflammatory effects. D: HSC is stimulated by secreted proteins from
    other cell types and switches from a resting state to an activated state, producing
    collagen which in turn causes fibrosis. E-F: LSEC secretes VCAM-1 in a lipotoxic
    environment, and monocytes have receptors for VCAM-1 on their surface. Adhesion
    of LSEC to monocytes can contribute to the conversion of monocytes to M2 macrophages.
    G: CD8 T-cell production of auto-aggression involves IL-15-driven transcriptional
    programming. Self-attack by CD8 T cells in the liver is involved in liver injury
    via cell death pathways. Abbreviations: DNL: de novo lipogenesis; ECM: extra cellular
    matrix; IRE1a: nucleus signaling 1; LSEC: Liver sinusoids endothelial cell; PGC1a:
    PPAR-gamma co-activator-1 alpha; PSS1: phosphatidylserine synthase1; SCOT: succinyl-CoA:3-ketoacid
    CoA transferase; TBK1: TANK-binding kinase 1; VCAM1: vascular cell adhesion molecule-1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Acaca
  - Pkm
  - Oxct2a
  - Oxct1
  - Hps3
  - Mertk
  - Ephb2
  - Mapk1
  - Prep
  - Il18
  - Ugt2b5
  - Acox1
  - Tbk1
  - Acy1
  - anx
  - Anxty
  - Anxa5
  - Tgfb1
  - Ltbp1
  - Ptdss1
  - Nrgn
  - Foxa3
  - Per1
  - wam
  - Mir26a-1
  - Tgfa
  - Or10h1b
  - Ern1
  - Elf2
  - Efnb2
  - Eif2s2
  - Fasn
  - Ccl2
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Fasl
  - Wdtc1
  - Foxo1
  - .na.character
  - Zmym2
  - Cxcr6
  - Ephb1
  - Rock2
  - Mir26a
  - Srebf1
  - Faslg
  - ACACA
  - PKM
  - PKLR
  - OXCT1
  - MERTK
  - EPHB2
  - MAPK1
  - MAPK3
  - IL18
  - ACOX1
  - ACOX2
  - ACOX3
  - ACOXL
  - TBK1
  - ACSL1
  - ACSL3
  - ACSL4
  - ACSL5
  - ACSL6
  - ACY1
  - ANXA5
  - TGFB1
  - TGFB2
  - TGFB3
  - CDSN
  - PTDSS1
  - CARD14
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - FOXA3
  - PER1
  - MIR26A1
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - TGFA
  - DNASE2
  - ERN1
  - ELF2
  - EIF2S1
  - EIF2S3
  - EIF2S2
  - FASN
  - CCL2
  - CRYGC
  - CRYGEP
  - CCL1
  - CCL3L1
  - CCL3L3
  - CCL4L1
  - CCL4L2
  - CCL5
  - CCL7
  - CCL8
  - CCL11
  - CCL13
  - CCL14
  - CCL15
  - CCL16
  - CCL17
  - CCL18
  - CCL19
  - CCL20
  - CCL21
  - CCL22
  - CCL24
  - CCL25
  - CCL26
  - CCL27
  - CCL28
  - CXCL16
  - CXCL17
  - XCL1
  - XCL2
  - CCL3
  - CCL4
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - FASLG
  - FOXO1
  - ZMYM2
  - CXCR6
  - SCOT
  - Coa
  - Erk7
  - rl
  - pop
  - Acox57D-p
  - Acox57D-d
  - Acsl
  - a5
  - Prosalpha5
  - dpp
  - gbb
  - put
  - mav
  - Rok
  - Gprk1
  - Drl-2
  - Ire1
  - eIF2alpha
  - eIF2beta
  - FASN1
  - FASN2
  - Zw
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - foxo
  - Low
  - Fim
---
